Cell surface-exposed tetanus toxin fragment C produced by recombinant Bacillus anthracis protects against tetanus toxin

Infection and Immunity

Volumn 67, Issue 9, 1999, Pages 4847-4850

  Mesnage, Stéphane ^a   Weber Levy, Martine ^a   Haustant, Michel ^a   Mock, Michèle ^a   Fouet, Agnès ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TETANUS TOXIN;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ARTICLE; BACILLUS ANTHRACIS; GENE FUSION; GENETIC RECOMBINATION; HUMORAL IMMUNITY; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; TETANUS; VACCINE PRODUCTION;

BACILLUS ANTHRACIS;

EID: 0032774774     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.9.4847-4850.1999     Document Type: Article

References (30)

1. Bizzini, B., A. Turpin, and M. Raynaud. 1969. Production et purification de la toxine tétanique. Ann. Inst. Pasteur 116:686-712.
2. Brossier, F. Personal communication.
3. Chatfield, S. N., I. G. Charles, A. J. Makoff, M. D. Oxer, G. Dougan, D. Pickard, D. Slater, and N. F. Fairweather. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology 10:888-892.
4. Chen, I., T. M. Finn, L. Yanqing, Q. Guoming, R. Rappuoli, and M. Pizza. 1998. A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. Infect. Immun. 66:1648-1653.
5. Etienne-Toumelin, I., J.-C. Sirard, E. Duflot, M. Mock, and A. Fouet. 1995. Characterization of the Bacillus anthracis S-layer: cloning and sequencing of the structural gene. J. Bacteriol. 177:614-620.
6. Fairweather, N. F., V. A. Lyness, and D. J. Maskell. 1987. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli. Infect. Immun. 55:2541-2545.
7. Figueiredo, D., C. Turcotte, G. Frankel, Y. Li, O. Dolly, G. Wilkin, D. Marriott, N. Fairweather, and G. Dougan. 1995. Characterization of recombinant tetanus toxin derivatives suitable for vaccine development. Infect. Immun. 63:3218-3221.
8. Fouet, A., S. Mesnage, E. Tosi-Couture, P. Gounon, and M. Mock. 1997. Bacillus anthracis S-layer. FEMS Microbiol. Lett. 20:55-59.
9. Halpern, J. L., W. H. Habig, E. A. Neale, and S. Stibitz. 1990. Cloning and expression of functional fragment C of tetanus toxin. Infect. Immun. 58: 1004-1009.
10. Halpern, J. L., and A. Loftus. 1993. Characterization of the receptor-binding domain of tetanus toxin. J. Biol. Chem. 268:1188-1192.
11. Hambleton, P., J. A. Carman, and J. Melling. 1984. Anthrax: the disease in relation to vaccines. Vaccine 2:125-132.
12. Helting, T. B., and O. Zwisler. 1977. Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments. J. Biol. Chem. 252:187-193.
13. Leppla, S. 1995. Anthrax toxins, p. 543-572. In J. Moss, B. Iglewski, M. Vaughan, and A. T. Tu (ed.), Handbook of natural toxins, vol. 8. Bacterial toxins and virulence factors in disease. Marcel Dekker, Inc., New York, N.Y.
14. Lupas, A., H. Engelhardt, J. Peters, U. Santarius, S. Volker, and W. Baumeister. 1994. Domain structure of the Acetogenium kivui surface layer revealed by electron crystallography and sequence analysis. J. Bacteriol. 176:1224-1233.
15. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
16. Mesnage, S., E. Tosi-Couture, and A. Fouet. 1999. Production and cell surface anchoring of functional fusions between the SLH motifs of the Bacillus anthracis S-layer proteins and the Bacillus subtilis levansucrase. Mol. Microbiol. 31:927-936.
17. Mesnage, S., E. Tosi-Couture, P. Gounon, M. Mock, and A. Fouet. 1998. The capsule and S-layer: two independent and yet compatible macromolecular structures in Bacillus anthracis. J. Bacteriol. 180:52-58.
18. Mesnage, S., E. Tosi-Couture, M. Mock, P. Gounon, and A. Fouet. 1997. Molecular characterization of the Bacillus anthracis main S-layer component: evidence that it is the major cell-associated antigen. Mol. Microbiol. 23:1147-1155.
19. Miller, J. H. 1972. Experiments in molecular genetics, p. 352-355. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
20. Pezard, C., P. Berche, and M. Mock. 1991. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59:3472-3477.
21. Pezard, C., M. Weber, J.-C. Sirard, P. Berche, and M. Mock. 1995. Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect. Immun. 63:1369-1372.
22. Popoff, M. R. Personal communication.
23. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
24. Sirard, J.-C., C. Fayolle, C. de Chastellier, M. Mock, C. Leclerc, and P. Berche. 1997. Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes. J. Immunol. 159:4435-4443.
25. Sirard, J.-C., M. Weber, E. Duflot, M. R. Popoff, and M. Mock. 1997. A recombinant Bacillus anthracis strain producing Clostridium perfringens Ib component induces protection against iota toxins. Infect. Immun. 65:2029-2033.
26. Thorne, C. B. 1993. Bacillus anthracis, p. 113-124. In A. L. Sonenshein, J. A. Hoch, and R. Losick (ed.), Bacillus subtilis and other gram-positive bacteria. American Society for Microbiology, Washington, D.C.
27. Trieu-Cuot, P., C. Carlier, P. Martin, and P. Courvalin. 1987. Plasmid transfer by conjugation from Escherichia coli to Gram-positive bacteria. FEMS Microbiol. Lett. 48:289-294.
28. Trieu-Cuot, P., C. Carlier, C. Poyart-Salmeron, and P. Courvalin. 1991. Shuttle vectors containing a multiple cloning site and a lacZa gene for conjugal transfer of DNA from Escherichia coli to Gram-positive bacteria. Gene 102:99-104.
29. Wells, J. M., P. W. Wilson, P. M. Norton, M. J. Gasson, and R. W. F. Le Page. 1993. Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol. Microbiol. 8:1155-1162.
30. Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.